Prof Jérémie Calais presents a talk on FAP-targeted molecular radiotherapy in cancer patients.
He begins by explaining that the FAP (fibroblast activation protein) target is a stromal target and how this can be used for imaging.
Dr Calais goes on to compare FAP-targeted MRT (molecular radiotherapy) with PSMA MRT, highlighting that FAP-targeted MRT is not quite at the full potential yet.